News Feed Opinion Blog Posts Career Updates Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
September, 2025
September 2025
M T W T F S S
1234567
891011121314
15161718192021
22232425262728
2930  
Santosh Vardhana: How bispecific antibodies work in B-cell non-Hodgkin lymphomas
Photo taken from Lorenzo Falchi/X
Jul 8, 2024, 13:01

Santosh Vardhana: How bispecific antibodies work in B-cell non-Hodgkin lymphomas

Santosh Vardhana, Assistant Professor in the Human Oncology and Pathogenesis Program at Memorial Sloan Kettering Cancer Center, shared on X:

“It’s my pleasure to share a preprint describing Lorenzo Falchi and Vardhana Lab explorations into how bispecific antibodies work in B-cell non-Hodgkin lymphomas.”

‘Intratumoral T-cell composition predicts epcoritamab-based treatment efficacy in B-cell non-Hodgkin lymphomas‘

Authors: Lorenzo Falchi, Jahan Rahman, Lauren Melendez, Monifa Douglas, Walter Ramos Amador, Paul Hamlin, Anita Kumar, Daniela Hoehn, Ya-Hui Lin, Qi Gao, Mikhail Roshal, Mark Ewalt, Ahmet Dogan, Benjamin D. Greenbaum, Gilles Salles, Santosha A Vardhana

Source: Santosh Vardhana/X

B-cell non-Hodgkin lymphoma cancer Lorenzo Falchi OncoDaily Oncology Santosh Vardhana Vardhana Lab
Special Coverage
Societies
Sep 5, 2025, 03:27
Europe’s Progress on the Early Detection of Prostate Cancer - European Cancer Organization
Voices
Sep 5, 2025, 03:11
Sumanta Pal: What Role Does Metabolism Play in Cancer Progression and Treatment?
Voices
Sep 5, 2025, 03:08
Polikalipo Kagina: Strengthening Radiotherapy Awareness and Support
Insight
Sep 5, 2025, 03:04
Luca Boldrini: A New Era in Radiation Oncology
Voices
Sep 4, 2025, 23:59
Roberto Borea: Selected Liquid Biopsy Abstracts for WCLC25
Insight
Sep 4, 2025, 20:03
Aruni Ghose: AI-Enhanced Medical Imaging for Cancer Diagnosis
Insight
Sep 4, 2025, 19:35
A Reminder That Education Is Essential to Patient Care - Elekta
Dialogues
Sep 4, 2025, 18:19
MASCC 2025 Presidential Training Fellowship Spotlight: Dr. Colleen Ann Cuthbert
Immune Oncology
Sep 4, 2025, 16:49
LIBRETTO-431 East Asia Subgroup Results of First-line Selpercatinib vs Chemotherapy + Pembrolizumab in RET Fusion–Positive NSCLC
OncoDaily Pulse
Sep 4, 2025, 16:17
Mariam Sargsyan: Meet the Experts of VIRO 2025
Voices
Sep 4, 2025, 15:59
Markus Kosch: Finding Strength After Diagnosis - A Conversation with Claudia Poguntke
Voices
Sep 4, 2025, 15:59
Common Sense Oncology India Hub Webinar – Insights on the MATTERHORN Trial